RPG Life eyes allies to enter US market

BUSINESS STANDARD, KOLKATA, 15.06.2007

RPG Life Sciences is in talks with seven global drug companies, including two domestic firms, to form pacts to enter the US market. "We hope to file six drug master files with the US Food and Drug Administration (US FDA), seeking permission to market active pharmaceutical ingredients. We will market speciality products in the field of cardiovascular drugs, oncology, nephrology and pain management in the European and the US markets. We will soon announce some major alliances," said Arvind Vasudeva, managing director, RPG Life Sciences.